(Q34204338)

31 July 2017

1 reference

title

Therapeutic potential of CRF receptor antagonists: a gut-brain perspective (English)

1 reference

31 July 2017

2

Taché Y

1 reference

31 July 2017

Heinrichs SC

1

1 reference

PubMed ID

11281815

31 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

Expert Opinion on Investigational Drugs

31 July 2017

1 reference

31 July 2017

10

1 reference

31 July 2017

4

1 reference

31 July 2017

647-659

1 reference

Receptors for gut regulatory peptides.

31 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Peptidergic regulation of gastrointestinal motility in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Peptide hormone evolution: functional heterogeneity within GnRH and CRF families

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Corticotropin-releasing factor, norepinephrine, and stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Distribution and concentration of urocortin, and effect of adrenalectomy on its content in rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Urocortin mRNA is expressed in the enteric nervous system of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Activation of urocortin transport into brain by leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Characterization of corticotropin-releasing factor receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

D-amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2beta receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Expression and characterisation of human and rat CRF2alpha receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Corticotropin-releasing hormone and animal models of anxiety: gene-environment interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Delayed gastric emptying in bulimic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Body dissatisfaction, bulimia, and depression among women: the mediating role of drive for thinness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Corticotropin-releasing hormone and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Local production of corticotropin releasing hormone is increased in experimental intestinal inflammation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

High-affinity binding of urocortin and astressin but not CRF to G protein-uncoupled CRFR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Appetite-suppressing effects of urocortin, a CRF-related neuropeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Intracisternal sauvagine is more potent than corticotropin-releasing factor to decrease gastric vagal efferent activity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Peripheral administration of a corticotropin-releasing factor antagonist increases the vocalizing and locomotor activity of isolated guinea pig pups

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Peripheral administration of CRF and urocortin: effects on food intake and the HPA axis in the marsupial Sminthopsis crassicaudata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Level of chronic life stress predicts clinical outcome in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

A corticotropin-releasing hormone type I receptor antagonist delays parturition in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.647

10.1517/13543784.10.4.647

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11281815